Related Experiment Video
Updated: May 7, 2026
06:38
Author Spotlight: Advancing Organoid Generation for Drug Development Using iPSCs
Published on: March 15, 2024
2.6K
A clinically defined and xeno-free hydrogel system for regenerative medicine
John Ong1,2,3,4, George Gibbons5, Yee Siang Lim6
1Department of Engineering, University of Cambridge, Trumpington Street, Cambridge CB2 1PZ, United Kingdom.
Materials Futures
|May 6, 2026
Summary
Researchers developed a novel human-derived hydrogel system for regenerative medicine. This biofabricated scaffold enhances human pluripotent stem cell (hPSC) differentiation and improves cell retention for tissue engineering therapies.
Area of Science:
- Biomaterials Science
- Stem Cell Biology
- Regenerative Medicine
Background:
- Biofabrication using human pluripotent stem cells (hPSCs) is crucial for tissue engineering.
- Current scaffolds often use poorly defined xenogenic or underdeveloped synthetic materials, limiting clinical translation.
- There is a need for well-defined, human-derived biomaterials to support hPSC differentiation and tissue development.
Purpose of the Study:
- To develop and characterize a novel hydrogel system using human-derived components for hPSC applications.
- To evaluate the ability of the hydrogel to support trilineage differentiation of hPSCs.
- To assess the efficacy of an organ-specific hydrogel for enhancing hepatocyte differentiation and improving cell retention in vivo.
Main Methods:
- A protein screen-based hydrogel system, 'Alphagel', was created using human embryonic matrices.
- Alphagel's ability to support trilineage differentiation (neural, cardiac, liver) of hPSCs was tested.
- A modified hydrogel, 'Hepatogel', was formulated with human foetal liver proteins to enhance hepatocyte differentiation.
- In vivo biocompatibility and biodegradability of Alphagel were assessed.
- Hepatogel's performance in enhancing hPSC-derived hepatocyte (H-iHeps) differentiation and retention in mouse livers was compared to Matrigel and standard injections.
Main Results:
- Alphagel supported the trilineage differentiation of hPSCs into neural, cardiac, and liver tissues.
- Alphagel demonstrated biocompatibility and biodegradability in vivo.
- Hepatogel significantly enhanced the differentiation of hPSC-derived hepatocytes compared to Matrigel.
- Hepatogel injection into mouse livers markedly improved H-iHeps retention compared to aqueous cell injections.
Conclusions:
- Customizable, organ-specific hydrogel systems derived from human components are feasible.
- These biofabricated hydrogels represent a promising tool for advancing regenerative medicine and tissue engineering.
- The developed hydrogel system offers a pathway towards clinically translatable lab-grown therapies.
